Welcome to LookChem.com Sign In|Join Free

CAS

  • or

638-95-9

Post Buying Request

638-95-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

638-95-9 Usage

Definition

ChEBI: A pentacyclic triterpenoid that is ursane which contains a double bond between positions 12 and 13 and in which the hydrogen at the 3beta position is substituted by a hydroxy group.

Purification Methods

Purify it by acetylation to the acetate followed by hydrolysis and recrystallisation from aqueous MeOH or from EtOH. The acetate when crystallised from pet ether, n-heptane or CHC

Check Digit Verification of cas no

The CAS Registry Mumber 638-95-9 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,3 and 8 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 638-95:
(5*6)+(4*3)+(3*8)+(2*9)+(1*5)=89
89 % 10 = 9
So 638-95-9 is a valid CAS Registry Number.

638-95-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma-Aldrich

  • (53017)  α-Amyrin  analytical standard

  • 638-95-9

  • 53017-10MG-F

  • 2,122.38CNY

  • Detail

638-95-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name α-amyrin

1.2 Other means of identification

Product number -
Other names A-AMYRIN

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:638-95-9 SDS

638-95-9Synthetic route

urs-12-en-3β-yl acetate
863-76-3, 101915-52-0, 22395-84-2

urs-12-en-3β-yl acetate

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
With potassium hydroxide In methanol Reflux;99%
Stage #1: urs-12-en-3β-yl acetate With methanol; sodium methylate at 20℃; for 2h;
Stage #2:
92%
With methanol; sodium methylate at 20℃; for 2h;88%
With potassium hydroxide In methanol
With potassium hydroxide In ethanol for 3h; Deacetylation; Heating;
(3β)-3-{[(1,1-dimethylethyl)dimethylsilyl]oxy}-urs-12-en

(3β)-3-{[(1,1-dimethylethyl)dimethylsilyl]oxy}-urs-12-en

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride In tetrahydrofuran at 20℃; for 14h; Reagent/catalyst; Solvent;94%
urs-12-en-3-one
638-96-0

urs-12-en-3-one

aluminum isopropoxide
555-31-7

aluminum isopropoxide

A

α-amyrin
638-95-9

α-amyrin

B

3α-hydroxyurs-12-ene
5937-48-4

3α-hydroxyurs-12-ene

Conditions
ConditionsYield
With isopropyl alcohol
urs-12-en-3-one
638-96-0

urs-12-en-3-one

A

α-amyrin
638-95-9

α-amyrin

B

3α-hydroxyurs-12-ene
5937-48-4

3α-hydroxyurs-12-ene

Conditions
ConditionsYield
With nickel Hydrogenation;
3α-acetoxy-ursen-(12)-al-(24)-semicarbazone

3α-acetoxy-ursen-(12)-al-(24)-semicarbazone

sodium ethanolate
141-52-6

sodium ethanolate

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
at 200℃;
3β-acetoxy-ursen-(12)-al-(28)-semicarbazone

3β-acetoxy-ursen-(12)-al-(28)-semicarbazone

sodium ethanolate
141-52-6

sodium ethanolate

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
at 200℃;
urs-12-en-3-one
638-96-0

urs-12-en-3-one

aluminum isopropoxide
555-31-7

aluminum isopropoxide

isopropyl alcohol
67-63-0

isopropyl alcohol

A

α-amyrin
638-95-9

α-amyrin

B

3α-hydroxyurs-12-ene
5937-48-4

3α-hydroxyurs-12-ene

(3β)-urs-12-en-3-yl palmitate
22255-10-3

(3β)-urs-12-en-3-yl palmitate

A

1-Hexadecanol
36653-82-4

1-Hexadecanol

B

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
With lithium aluminium tetrahydride
α-L-rhamnopyranosyl-(1->4)-β-D-glucopyranosyl-(1->3)-α-amyrin

α-L-rhamnopyranosyl-(1->4)-β-D-glucopyranosyl-(1->3)-α-amyrin

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
With sulfuric acid In ethanol
fraction No3 of Canarium zeylanicum benzene extract

fraction No3 of Canarium zeylanicum benzene extract

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
With nitric acid; sodium chloride In pyridine at 0℃; for 0.2h;2.9 g
urs-12-en-3-one
638-96-0

urs-12-en-3-one

Raney nickel

Raney nickel

A

α-amyrin
638-95-9

α-amyrin

B

3α-hydroxyurs-12-ene
5937-48-4

3α-hydroxyurs-12-ene

Conditions
ConditionsYield
Hydrogenation;
3β-acetoxy-ursen-(12)-one-(16)
107657-17-0

3β-acetoxy-ursen-(12)-one-(16)

sodium ethanolate
141-52-6

sodium ethanolate

hydrazine
302-01-2

hydrazine

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
at 250℃;
neoilexonol
2118-90-3

neoilexonol

acetic acid
64-19-7

acetic acid

platinum

platinum

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
Hydrogenation;
(3β)-urs-12-en-3-yl palmitate
22255-10-3

(3β)-urs-12-en-3-yl palmitate

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
With potassium hydroxide In ethanol
Conditions
ConditionsYield
With trifluorormethanesulfonic acid In chloroform-d1 at 23℃; for 24h; Inert atmosphere;A 10 %Spectr.
B 15 %Spectr.
C 10 %Spectr.
D 17 %Spectr.
E 29 %Spectr.
F 12 %Spectr.
Conditions
ConditionsYield
With trifluorormethanesulfonic acid In chloroform-d1 at 23℃; for 12h; Inert atmosphere;A 12 %Spectr.
B 8 %Spectr.
C 17 %Spectr.
D 46 %Spectr.
E 12 %Spectr.
urs-12-ene-3β-tetradecanoate

urs-12-ene-3β-tetradecanoate

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
With methanol; sodium hydroxide for 10h;
urs-12-ene-3β-decanoate
149695-97-6

urs-12-ene-3β-decanoate

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
With methanol; sodium hydroxide for 10h;
urs-12-ene-3β-dodecanoate

urs-12-ene-3β-dodecanoate

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
With methanol; sodium hydroxide for 10h;
isoursenol
14459-13-3

isoursenol

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
With trifluorormethanesulfonic acid In chloroform-d1 at 23℃; for 0.25h;93 %Spectr.
methanol
67-56-1

methanol

3β-12-ursen-3-yl docosanoate

3β-12-ursen-3-yl docosanoate

A

behenic acid methyl ester
929-77-1

behenic acid methyl ester

B

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
With potassium hydroxide
methanol
67-56-1

methanol

3β-12-ursen-3-yl nonacosanoate

3β-12-ursen-3-yl nonacosanoate

A

nonacosanoic acid methyl ester
4082-55-7

nonacosanoic acid methyl ester

B

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
With potassium hydroxide
(3β)-3-{[(1,1-dimethylethyl)dimethylsilyl]oxy}-28-{[(trifluoromethyl)sulfonyl]oxy}-urs-12-en

(3β)-3-{[(1,1-dimethylethyl)dimethylsilyl]oxy}-28-{[(trifluoromethyl)sulfonyl]oxy}-urs-12-en

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 4 h / 0 - 20 °C
2: tetrabutyl ammonium fluoride / tetrahydrofuran / 14 h / 20 °C
View Scheme
ursolic acid
77-52-1

ursolic acid

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: potassium carbonate / N,N-dimethyl-formamide / 0.5 h
1.2: 12 h / 20 °C
2.1: 1H-imidazole / N,N-dimethyl-formamide / 24 h / 50 °C
3.1: lithium aluminium tetrahydride / tetrahydrofuran / 0 °C / Reflux
4.1: pyridine / dichloromethane / 0.25 h / 0 °C
5.1: lithium aluminium tetrahydride / tetrahydrofuran / 4 h / 0 - 20 °C
6.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 14 h / 20 °C
View Scheme
Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 1H-imidazole / N,N-dimethyl-formamide / 24 h / 50 °C
2: lithium aluminium tetrahydride / tetrahydrofuran / 0 °C / Reflux
3: pyridine / dichloromethane / 0.25 h / 0 °C
4: lithium aluminium tetrahydride / tetrahydrofuran / 4 h / 0 - 20 °C
5: tetrabutyl ammonium fluoride / tetrahydrofuran / 14 h / 20 °C
View Scheme
(3β)-methyl 3-{[(1,1-dimethylethyl)dimethylsilyl]oxy}-urs-12-en-28-oate
197500-54-2

(3β)-methyl 3-{[(1,1-dimethylethyl)dimethylsilyl]oxy}-urs-12-en-28-oate

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 °C / Reflux
2: pyridine / dichloromethane / 0.25 h / 0 °C
3: lithium aluminium tetrahydride / tetrahydrofuran / 4 h / 0 - 20 °C
4: tetrabutyl ammonium fluoride / tetrahydrofuran / 14 h / 20 °C
View Scheme
(3β)-3-{[(1,1-dimethylethyl)dimethylsilyl]oxy}-urs-12-en-28-ol
197500-55-3

(3β)-3-{[(1,1-dimethylethyl)dimethylsilyl]oxy}-urs-12-en-28-ol

α-amyrin
638-95-9

α-amyrin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: pyridine / dichloromethane / 0.25 h / 0 °C
2: lithium aluminium tetrahydride / tetrahydrofuran / 4 h / 0 - 20 °C
3: tetrabutyl ammonium fluoride / tetrahydrofuran / 14 h / 20 °C
View Scheme
α-amyrin
638-95-9

α-amyrin

urs-12-en-3-one
638-96-0

urs-12-en-3-one

Conditions
ConditionsYield
With pyridinium chlorochromate In dichloromethane at 20℃; for 12h;90%
With chromium(VI) oxide; sulfuric acid In acetone
With 4-methylisopropylbenzene; nickel Heating;
nicotinic acid
59-67-6

nicotinic acid

α-amyrin
638-95-9

α-amyrin

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a, 14,14a,14b-icosahydropicen-3-ylnicotinate
1443125-09-4

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a, 14,14a,14b-icosahydropicen-3-ylnicotinate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 4h;85%
α-amyrin
638-95-9

α-amyrin

para-chlorobenzoic acid
74-11-3

para-chlorobenzoic acid

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 4-chlorobenzoate
1010707-21-7

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 4-chlorobenzoate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 4h;80%
n-hexanoic anhydride
2051-49-2

n-hexanoic anhydride

α-amyrin
638-95-9

α-amyrin

urs-12-ene-3β-hexanoate
130838-16-3

urs-12-ene-3β-hexanoate

Conditions
ConditionsYield
With dmap In dichloromethane for 3h;77%
α-amyrin
638-95-9

α-amyrin

5-oxo-5-phenylvaleric acid
1501-05-9

5-oxo-5-phenylvaleric acid

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 5-oxo-5-phenylpentanoate
1146582-50-4

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 5-oxo-5-phenylpentanoate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 4h;72%
α-amyrin
638-95-9

α-amyrin

4-nitro-benzoic acid
62-23-7

4-nitro-benzoic acid

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 4-nitrobenzoate

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 4-nitrobenzoate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 4h;72%
α-amyrin
638-95-9

α-amyrin

acetic anhydride
108-24-7

acetic anhydride

urs-12-en-3β-yl acetate
863-76-3, 101915-52-0, 22395-84-2

urs-12-en-3β-yl acetate

Conditions
ConditionsYield
With dmap In dichloromethane for 3h;71%
With pyridine
With pyridine
With pyridine for 5h; Heating;
α-amyrin
638-95-9

α-amyrin

1-hexadecylcarboxylic acid
57-10-3

1-hexadecylcarboxylic acid

(3β)-urs-12-en-3-yl palmitate
22255-10-3

(3β)-urs-12-en-3-yl palmitate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 18h; Acetylation;68%
4-Methoxyphenylacetic acid
104-01-8

4-Methoxyphenylacetic acid

α-amyrin
638-95-9

α-amyrin

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 2-(4-methoxyphenyl)acetate
1146582-48-0

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 2-(4-methoxyphenyl)acetate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 4h;54%
2-Picolinic acid
98-98-6

2-Picolinic acid

α-amyrin
638-95-9

α-amyrin

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl nicotinate
1146582-54-8

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl nicotinate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 4h;53%
α-amyrin
638-95-9

α-amyrin

A-neo-ursa-3(5),12-diene
127603-20-7

A-neo-ursa-3(5),12-diene

Conditions
ConditionsYield
With phosphorus pentaoxide In toluene for 2h; Heating;52%
α-amyrin
638-95-9

α-amyrin

4-(4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yloxy)-4-oxo-butanoic acid
57732-64-6

4-(4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yloxy)-4-oxo-butanoic acid

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl succinate
1146582-66-2

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl succinate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 4h;52%
quinoline-2-carboxylic acid
93-10-7

quinoline-2-carboxylic acid

α-amyrin
638-95-9

α-amyrin

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl isoquinoline-1-carboxylate
1146582-56-0

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl isoquinoline-1-carboxylate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 4h;51%
succinic acid anhydride
108-30-5

succinic acid anhydride

α-amyrin
638-95-9

α-amyrin

4-(4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yloxy)-4-oxo-butanoic acid
57732-64-6

4-(4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yloxy)-4-oxo-butanoic acid

Conditions
ConditionsYield
With dmap In dichloromethane at 20℃; for 4h;48%
α-amyrin
638-95-9

α-amyrin

A

urs-12-en-3-one
638-96-0

urs-12-en-3-one

B

3,11-dioxo α-amyrin
38242-01-2

3,11-dioxo α-amyrin

Conditions
ConditionsYield
With chromium(VI) oxide In acetic acid for 48h; Ambient temperature;A 47%
B 24%
With chromium(VI) oxide In acetic acid Ambient temperature;A 47%
B 24%
Angelic acid
565-63-9

Angelic acid

α-amyrin
638-95-9

α-amyrin

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl (Z)-2-methylbut-2-enoate

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl (Z)-2-methylbut-2-enoate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 4h;46%
Hippuric Acid
495-69-2

Hippuric Acid

α-amyrin
638-95-9

α-amyrin

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 2-benzamidoacetate
1146582-60-6

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 2-benzamidoacetate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 4h;43%
α-amyrin
638-95-9

α-amyrin

2,5-dimethylbenzoic acid
610-72-0

2,5-dimethylbenzoic acid

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 2,5-dimethylbenzoate
1146582-62-8

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 2,5-dimethylbenzoate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 4h;43%
phthalic anhydride
85-44-9

phthalic anhydride

α-amyrin
638-95-9

α-amyrin

2-(4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yloxy)carbonylbenzoic acid
1011714-98-9

2-(4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yloxy)carbonylbenzoic acid

Conditions
ConditionsYield
With dmap In dichloromethane at 20℃; for 4h;42%
α-amyrin
638-95-9

α-amyrin

2-Bromopropionic acid
598-72-1

2-Bromopropionic acid

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 2-bromopropanoate
1146582-58-2

4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl 2-bromopropanoate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 4h;35%
pyridine
110-86-1

pyridine

α-amyrin
638-95-9

α-amyrin

propionyl chloride
79-03-8

propionyl chloride

urs-12-ene-3β-propionate
115653-34-4

urs-12-ene-3β-propionate

Conditions
ConditionsYield
With diethyl ether
pyridine
110-86-1

pyridine

α-amyrin
638-95-9

α-amyrin

Stearoyl chloride
112-76-5

Stearoyl chloride

(3β)-urs-12-en-3-yl stearate
63195-78-8

(3β)-urs-12-en-3-yl stearate

Conditions
ConditionsYield
With diethyl ether
pyridine
110-86-1

pyridine

α-amyrin
638-95-9

α-amyrin

Trichloroacetyl chloride
76-02-8

Trichloroacetyl chloride

O-trichloroacetyl-α-amyrin

O-trichloroacetyl-α-amyrin

Conditions
ConditionsYield
With diethyl ether
formic acid
64-18-6

formic acid

α-amyrin
638-95-9

α-amyrin

urs-12-ene-3β-formiate
6201-95-2

urs-12-ene-3β-formiate

α-amyrin
638-95-9

α-amyrin

beta-amyrin
559-70-6

beta-amyrin

6-Hydroxy-1.2.5-trimethyl-naphthalin
108368-99-6

6-Hydroxy-1.2.5-trimethyl-naphthalin

Conditions
ConditionsYield
With selenium at 350℃;
α-amyrin
638-95-9

α-amyrin

beta-amyrin
559-70-6

beta-amyrin

10-hydroxy-2.9-dimethyl-picene

10-hydroxy-2.9-dimethyl-picene

Conditions
ConditionsYield
With selenium at 350℃;
α-amyrin
638-95-9

α-amyrin

N-chlorobetainyl chloride
53684-57-4

N-chlorobetainyl chloride

trimethyl-urs-12-en-3β-yloxycarbonylmethyl-ammonium; chloride
124107-50-2

trimethyl-urs-12-en-3β-yloxycarbonylmethyl-ammonium; chloride

Conditions
ConditionsYield
With chloroform
α-amyrin
638-95-9

α-amyrin

1,2,7-trimethylnaphthalene
486-34-0

1,2,7-trimethylnaphthalene

Conditions
ConditionsYield
With selenium
With sulfur

638-95-9Relevant articles and documents

Laird et al.

, p. 4108 (1960)

Synthesis of novel triterpene and N-allylated/N-alkylated niacin hybrids as α-glucosidase inhibitors

Narender, Tadigoppula,Madhur, Gaurav,Jaiswal, Natasha,Agrawal, Manali,Maurya, Chandan K.,Rahuja, Neha,Srivastava, Arvind K.,Tamrakar, Akhilesh K.

, p. 162 - 169 (2013)

Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia. α-Glucosidase (EC 3.2.1.20) inhibitors interfere with enzymatic action to slow down the liberation of d-glucose from oligosaccharides and disaccharides, resulting in delayed glucose absorption and decreased postprandial plasma glucose levels. In continuation of our drug discovery program on antidiabetic agents, we synthesized novel N-allylated/N-alkylated niacin and α-amyrin (4-9) and lupeol (12-16) hybrids and tested for their α-glucosidase inhibiting activity. Compounds 4-9 showed better activity profile than the marketed α-glucosidase inhibitor i.e. acarbose. Compound 4 possess the highest inhibitory action with IC50 of 5 μM. Kinetic and CD studies revealed that 4 inhibited the α-glucosidase in a noncompetitive manner and caused conformational changes in secondary structure of the enzyme protein.

Kohen,F. et al.

, p. 2710 - 2714 (1964)

An improved scalable synthesis of α- and β-amyrin

Serbian, Immo,Csuk, René

, (2018/07/13)

The synthesis of α- and β-amyrin was accomplished starting from easily accessible starting materials, oleanolic, and ursolic acid. The procedures allow the preparation of β-amyrin in an exceptionally short scalable manner via selective iodation and reduction. For α-amyrin, a different synthetic approach had to be chosen providing access to α-amyrin in medium-to-large scale.

Practical Synthesis of α-Amyrin, β-Amyrin, and Lupeol: The Potential Natural Inhibitors of Human Oxidosqualene Cyclase

Chen, Dongyin,Xu, Fengguo,Zhang, Pu,Deng, Jie,Sun, Hongbin,Wen, Xiaoan,Liu, Jun

, (2017/10/20)

A practical synthesis of α-amyrin (1), β-amyrin (2), and lupeol (3) was accomplished in total yields of 32, 42, and 40% starting from easily available ursolic acid (4), oleanolic acid (5), and betulin (6), respectively. Remarkably, these three natural pentacyclic triterpenes exhibited potential inhibitory activity against human oxidosqualene cyclase.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 638-95-9